# Effects of hyperbaric oxygen combined cabin ventilator on critically ill patients with liberation difficulty after tracheostomy

**Authors:** Yinliang Qi, Jixiang Xu, Hui Liu, Xiaomei Zhou

PMC · DOI: 10.1186/s12938-024-01220-4 · BioMedical Engineering OnLine · 2024-03-07

## TL;DR

This study explores how combining hyperbaric oxygen with ventilator therapy helps critically ill patients who struggle to breathe independently after tracheostomy.

## Contribution

The novel approach combines hyperbaric oxygen and ventilator therapy to improve outcomes in patients with liberation difficulty after tracheostomy.

## Key findings

- Patients treated with hyperbaric oxygen and ventilator therapy showed improved GCS, blood gas indicators, and cardiac function.
- The SL group had significantly better improvements in PaO2, SaO2, and OI compared to the NSL group.
- No significant difference was found in left ventricular function indicators between the two groups.

## Abstract

Critically ill patients undergoing liberation often encounter various physiological and clinical complexities and challenges. However, whether the combination of hyperbaric oxygen and in-cabin ventilator therapy could offer a comprehensive approach that may simultaneously address respiratory and potentially improve outcomes in this challenging patient population remain unclear.

This retrospective study involved 148 patients experiencing difficulty in liberation after tracheotomy. Inclusion criteria comprised ongoing mechanical ventilation need, lung inflammation on computed tomography (CT) scans, and Glasgow Coma Scale (GCS) scores of ≤ 9. Exclusion criteria excluded patients with active bleeding, untreated pneumothorax, cerebrospinal fluid leakage, and a heart rate below 50 beats per minute. Following exclusions, 111 cases were treated with hyperbaric oxygen combined cabin ventilator, of which 72 cases were successfully liberated (SL group) and 28 cases (NSL group) were not successfully liberated. The hyperbaric oxygen chamber group received pressurization to 0.20 MPa (2.0 ATA) for 20 min, followed by 60 min of ventilator oxygen inhalation. Successful liberation was determined by a strict process, including subjective and objective criteria, with a prolonged spontaneous breathing trial. GCS assessments were conducted to evaluate consciousness levels, with scores categorized as normal, mildly impaired, moderately impaired, or severely impaired.

Patients who underwent treatment exhibited improved GCS, blood gas indicators, and cardiac function indexes. The improvement of GCS, partial pressure of oxygen (PaO2), oxygen saturation of blood (SaO2), oxygenation index (OI) in the SL group was significantly higher than that of the NSL group. However, there was no significant difference in the improvement of left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), left ventricular end-diastolic volume (LVEDV), and stroke volume (SV) between the SL group and the NSL group after treatment.

Hyperbaric oxygen combined with in-cabin ventilator therapy effectively enhances respiratory function, cardiopulmonary function, and various indicators of critically ill patients with liberation difficulty after tracheostomy.

The online version contains supplementary material available at 10.1186/s12938-024-01220-4.

## Full-text entities

- **Diseases:** bleeding (MESH:D006470), pneumothorax (MESH:D011030), inflammation (MESH:D007249), cerebrospinal fluid leakage (MESH:D065634), Critically ill (MESH:D016638), Coma (MESH:D003128), stroke (MESH:D020521)
- **Chemicals:** oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10921656/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10921656/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC10921656/full.md

---
Source: https://tomesphere.com/paper/PMC10921656